Delivery Order SPE2DB24D1021-SPE2DB25FERNH

Award Date 10/22/24
Potential Completion Date 11/13/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,335.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COMIRNATY 2024-25 (12Y UP) syringes (0.3ML). The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award, valued at $7,335.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of COMIRNATY 2024-25 (12 years and up) syringes, 0.3 mL, and is a firm fixed-price delivery order with a completion date of November 6, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,467.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25 syringes (0.3 ML) for individuals 12 years and older, with a completion date of November 12, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,293.36, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 ML. This is a firm fixed price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,724.48, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes in 0.3 mL doses. The contract is a Firm Fixed Price Delivery Order with a completion date of December 5, 2024. The contract was awarded on November 13, 2024 and was not designated as a set-aside contract. AmerisourceBergen Drug...
This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes, 0.3 mL, to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,310.25 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on September 24, 2024, with a completion date of September 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,701.40 Firm Fixed Price delivery order contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes with a 0.3 mL volume. The contract has an ultimate completion date of December 17, 2024 and was awarded on November 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,480.58, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes in 0.3ML quantities. The contract is a Firm Fixed Price Delivery Order with a completion date of December 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,002.50 delivery order contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 mL, with a completion date of November 15, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,335 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables efficient government procurement of essential pharmaceutical and medical supplies, including specialty...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FERNH
    Delivery Order

This federal contract award, valued at $5,134.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes in 0.3 ml doses. It is a firm-fixed-price delivery order that will be completed by November 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 1/22/25, 1:00 AM